Koelle G B, Sanville U J, Thampi N S
Department of Pharmacology, School of Medicine, University of Pennsylvania, Philadelphia 19104-6084.
Proc Natl Acad Sci U S A. 1987 Oct;84(19):6944-7. doi: 10.1073/pnas.84.19.6944.
Intracarotid infusion of glycyl-L-glutamine (Gly-Gln) was shown previously to oppose the fall in the acetylcholinesterase and butyrylcholinesterase contents of the cat superior cervical ganglion (SCG) that otherwise follows preganglionic denervation. However, its effect was demonstrable only on the vascularly remote left SCG but not on the directly infused right SCG. Accordingly, it was concluded that a metabolite of Gly-Gln, formed in the blood, is an active neurotrophic factor. Glycyl-L-glutamic acid and L-glutamic acid were subsequently found to have a similar but less marked effect on both SCG. In the present study an alternative explanation has been tested: that Gly-Gln must combine slowly with some component of plasma to enable it to penetrate the ganglion cells and exert its neurotrophic effect. Findings are consistent with the latter proposal.
先前的研究表明,颈内动脉注入甘氨酰-L-谷氨酰胺(Gly-Gln)可对抗猫颈上神经节(SCG)中乙酰胆碱酯酶和丁酰胆碱酯酶含量的下降,否则这种下降会在节前神经去神经支配后出现。然而,其作用仅在血管较远的左侧SCG上得到证实,而在直接注入的右侧SCG上未得到证实。因此,得出的结论是,在血液中形成的Gly-Gln代谢产物是一种活性神经营养因子。随后发现甘氨酰-L-谷氨酸和L-谷氨酸对两个SCG都有类似但不太明显的作用。在本研究中,对另一种解释进行了验证:Gly-Gln必须与血浆中的某些成分缓慢结合,使其能够穿透神经节细胞并发挥其神经营养作用。研究结果与后一种观点一致。